46
MEDYA
TR
EN
Home
Genel
News Detail
Morning Star
May 30, 2026
|
15:17
Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026
...
Full Story at Source
Related News
WHO chief lands in eastern Congo’s Ituri province, epicenter of Ebola, as outbreak outpaces response
My golf buddy dropped me when I didn't ask him to be my financial adviser. Was I naive?
The company behind the White House's UFC event says rivals 'would kill' for the opportunity. Critics say that's a problem.
England vs India LIVE: Second women's T20, Bristol - cricket score, radio & highlights
